US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARK Genomic Revolution ETF

53.40

+0.23000.43%

Volume:2.30M

Turnover:123.96M

Market Cap:2.17B

PE:- -

High:54.78

Open:54.14

Low:53.10

Close:53.17

52wk High:55.30

52wk Low:24.60

Shares:40.65M

Float Shares:40.65M

Volume Ratio:0.98

T/O Rate:5.67%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

R3 Lithium focusing on lithium carbonate refining to tackle western black mass bottleneck, CEO Austin says

Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials

Cathie Wood’s ARK Investment buys 100K shares of Ionis Pharmaceuticals today

Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics today

European Lithium Sends Merger Scheme Booklet to Investors

Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24

Australian Clinical Labs lodges 2026 AGM materials and governance disclosures

Australian Clinical Labs publishes AGM materials and 2026 annual report

Twist Bioscience CEO Emily M. Leproust Disposes of USD 51.47 Million in Common Shares

Scandium Canada Adds Tech Veteran Noel Dubé to Board to Drive Alloy Commercialization

Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal

Tempus Extends Data Licensing Partnership with Recursion Through November 2029

Tempus AI, Recursion Extend Data License, Amend Fee Structure

MT Newswires Live

Recursion, Tempus Expand AI and RNA Collaboration Agreements

Tempus AI, Recursion extend data license agreement, enter new license agreement

Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm

THOMSON REUTERS

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model

THOMSON REUTERS

Tempus AI, -Co and Recursion Extend Data Partnership Through November 2029

THOMSON REUTERS

Hexcel to showcase advanced composite innovations at CAMX 2026

10x Genomics : Deutsche Bank Raises Target Price to $70 from $40

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/ARKG/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ARKG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","market":"US","secType":"STK","nameCN":"ARK Genomic Revolution ETF","latestPrice":53.4,"timestamp":1790963929377,"preClose":53.17,"halted":0,"volume":2303783,"delay":0,"changeRate":0.0043257476020311615,"floatShares":40650000,"shares":40650000,"eps":0,"marketStatus":"Trading","change":0.23,"latestTime":"10-02 13:58:56 EDT","open":54.14,"high":54.78,"low":53.1,"amount":123963798.69039999,"amplitude":0.031597,"askPrice":53.42,"askSize":225,"bidPrice":53.41,"bidSize":105,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":53.17,"sharesOutstanding":39900000,"nav":54.255912,"aum":2251620348,"bidAskSpread":0.000263,"preHourTrading":{"tag":"盘前","latestPrice":54.03,"preClose":53.17,"latestTime":"09:25 EDT","volume":8109,"amount":437539.42134,"timestamp":1790947507973,"change":0.86,"changeRate":0.016175,"amplitude":0.028023},"postHourTrading":{"tag":"盘后","latestPrice":53.25,"preClose":53.17,"latestTime":"19:55 EDT","volume":50680,"amount":2695931.3262,"timestamp":1790898935038,"change":0.08,"changeRate":0.001505,"amplitude":0.009137},"volumeRatio":0.979418,"impliedVol":0.4909,"impliedVolPercentile":0.3108},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","floatShares":40650000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.979418,"shares":40650000,"dividePrice":0,"high":54.78,"amplitude":0.031597,"preClose":53.17,"low":53.1,"week52Low":24.6,"pbRate":"--","week52High":55.3,"institutionHeld":0,"latestPrice":53.4,"committee":-0.363636,"eps":0,"divideRate":0,"volume":2303783,"delay":0,"ttmEps":0,"open":54.14,"prevYearClose":28.97,"prevWeekClose":53.36,"prevMonthClose":54.22,"prevQuarterClose":54.22,"fiveDayClose":53.36,"twentyDayClose":47.2,"sixtyDayClose":43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARKG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-29","symbol":"ARKG","amount":0.38239,"defaultRemindTime":1640788200000,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000},{"market":"US","date":"2020-12-29","symbol":"ARKG","amount":0.36456,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2020-12-31","payableDate":"2020-12-30","currency":"USD","type":"dividend","dateTimestamp":1609218000000},{"market":"US","date":"2019-12-27","symbol":"ARKG","amount":1.05395,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2019-12-31","payableDate":"2019-12-30","currency":"USD","type":"dividend","dateTimestamp":1577422800000},{"market":"US","date":"2018-12-27","symbol":"ARKG","amount":0.26999,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2018-12-31","payableDate":"2018-12-28","currency":"USD","type":"dividend","dateTimestamp":1545886800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARKG\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2018-12-31","value":0.26999,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":1.05395,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.36456,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":0.38239,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARKG\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARKG\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669117736","title":"R3 Lithium focusing on lithium carbonate refining to tackle western black mass bottleneck, CEO Austin says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669117736","media":"Fastmarkets","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669117736?lang=en_us&edition=fundamental","pubTime":"2026-09-22 12:00","pubTimestamp":1790049600,"startTime":"0","endTime":"0","summary":"A focus on producing secondary lithium carbonate through a network of post-treatment facilities is central to newly-formed R3 Lithium’s strategy for tackling undercapacity in western battery metals recycling, Linh Austin, the company’s chief executive officer, has told Fastmarkets in an exclusive interview.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fastmarkets_highlight","url":"https://www.fastmarkets.com/insights/r3-lithium-focusing-on-lithium-carbonate-refining-to-tackle-western-black-mass-bottleneck-ceo-austin-says/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fastmarkets.com/insights/r3-lithium-focusing-on-lithium-carbonate-refining-to-tackle-western-black-mass-bottleneck-ceo-austin-says/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fastmarkets_highlight","symbols":["CRSH","07366","TSDD","TSLY","TSL","TSLL","09366","TSYY","TSLW","TSLR","TSLP","TESL","09766","ELOL","BK4585","BK4588","ARKG","TSII","TSLO","TSLZ","CAM","TSLI","07766","SETM","TSLG","XME","TESC","TEST","FXZ","BK4535","BK4516","TSLS","TSLQ","TSLT","BK4544","TLA","LIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669192951","title":"Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2669192951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669192951?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:14","pubTimestamp":1790039644,"startTime":"0","endTime":"0","summary":"WOOJUNG BIO, Inc. ( ($KR:215380) ) has issued an update. Kolmar Biotech Co., Ltd., a biotechnology and advanced materials company based in Hwaseong...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","BBP","SYNB","IBB","BK4588","FWD","BK4585","UYM","LNGR","BK4581","ARKG","XBI","TYNE","AGNG","RSPH","IEIH","JDOC","DARP","TINT","FHLC","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669194598","title":"Cathie Wood’s ARK Investment buys 100K shares of Ionis Pharmaceuticals today","url":"https://stock-news.laohu8.com/highlight/detail?id=2669194598","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669194598?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:35","pubTimestamp":1790037313,"startTime":"0","endTime":"0","summary":"20:27 EDT Cathie Wood’s ARK Investment buys 100K shares of Ionis Pharmaceuticals (IONS) today Published first on TheFly – the ultimate source for r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-100k-shares-of-ionis-pharmaceuticals-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-100k-shares-of-ionis-pharmaceuticals-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","ARKW","BK4585","BK4588","ARKK","IONS","ARKX","BK4139","SARK","ARKF","ARKQ","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669911491","title":"Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics  today","url":"https://stock-news.laohu8.com/highlight/detail?id=2669911491","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669911491?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:30","pubTimestamp":1790037011,"startTime":"0","endTime":"0","summary":"20:28 EDT Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics (BEAM) today Published first on TheFly – the ultimate source for real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4556","BK4585","BK4535","BK4611","ARKK","ARKQ","SARK","LENZ","LU1861558580.USD","BK4588","ARKF","LU1861559042.SGD","BK4544","ARKX","BEAM","BK4139","BK4505","ARKG","ARKW","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669199992","title":"European Lithium Sends Merger Scheme Booklet to Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669199992","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669199992?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:57","pubTimestamp":1790035035,"startTime":"0","endTime":"0","summary":"European Lithium ( ($AU:EUR) ) just unveiled an update. European Lithium has begun dispatching its Scheme Booklet and proxy materials to securityho...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/european-lithium-sends-merger-scheme-booklet-to-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/european-lithium-sends-merger-scheme-booklet-to-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4544","LIT","BK4588","EPV","ISBC","SETM","ARKG","BK4585","EUFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669843196","title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843196","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669843196?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:41","pubTimestamp":1790030476,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics director Ali Behbahani disposes of common shares worth $780,649.24CRISPR Therapeutics director Ali Behbahani exercised stock options for 30,000 common shares at USD 14 on Sept. 17,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL112S6t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","BK4585","BK4139","BK4588","BK4611","CRSP","ARKG","LU1861558580.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196831","title":"Australian Clinical Labs lodges 2026 AGM materials and governance disclosures","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196831","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196831?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:33","pubTimestamp":1790030000,"startTime":"0","endTime":"0","summary":"An announcement from Australian Clinical Labs Ltd ( ($AU:ACL) ) is now available. Australian Clinical Labs has released the documentation for its 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/australian-clinical-labs-lodges-2026-agm-materials-and-governance-disclosures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/australian-clinical-labs-lodges-2026-agm-materials-and-governance-disclosures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","ARKG","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669519688","title":"Australian Clinical Labs publishes AGM materials and 2026 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2669519688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669519688?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:33","pubTimestamp":1790029992,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Australian Clinical Labs Ltd ( ($AU:ACL) ). Australian Clinical Labs has released key documents ahead of its 20...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/australian-clinical-labs-publishes-agm-materials-and-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/australian-clinical-labs-publishes-agm-materials-and-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARKG","BK4544","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669119897","title":"Twist Bioscience CEO Emily M. Leproust Disposes of USD 51.47 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669119897","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669119897?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:06","pubTimestamp":1790021163,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily M. Leproust disposes of USD 51.47 million in common sharesTwist Bioscience CEO Emily M. Leproust exercised employee stock options for 208,708 shares on Sept. 17, 2026.She so","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL6bV88H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience CEO Emily M. Leproust Disposes of USD 51.47 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","GNOM","BK4588","TWST","WDNA","ARKG","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669988991","title":"Scandium Canada Adds Tech Veteran Noel Dubé to Board to Drive Alloy Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2669988991","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669988991?lang=en_us&edition=fundamental","pubTime":"2026-09-22 03:09","pubTimestamp":1790017775,"startTime":"0","endTime":"0","summary":"The latest update is out from Imperial Mining Group Class A ( ($TSE:SCD) ). Scandium Canada Ltd., a Québec-based critical advanced materials compan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scandium-canada-adds-tech-veteran-noel-dube-to-board-to-drive-alloy-commercialization?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scandium-canada-adds-tech-veteran-noel-dube-to-board-to-drive-alloy-commercialization?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4588","BK4585","TINT","TYNE","BK4544"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162636","title":"Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162636","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162636?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:18","pubTimestamp":1790007493,"startTime":"0","endTime":"0","summary":"Recursion licenses TxFM RNA foundation model to Tempus AI for oncology use in USD 12 million dealRecursion Pharmaceuticals expanded its data partnership with Tempus AI, extending the term to six years","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL7Y7sX8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMC","BK4121","LU1861559042.SGD","BK4613","BK4539","BK4611","BK4609","ARKG","HEAL","RXRX","BK4548","TEMT","TEM","LU1861558580.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162688","title":"Tempus Extends Data Licensing Partnership with Recursion Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162688","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162688?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:17","pubTimestamp":1790007444,"startTime":"0","endTime":"0","summary":"Tempus extends data licensing partnership with Recursion through November 2029Tempus extended its multi-year data license partnership with Recursion through November 2029.Deal resets original master a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL8vkn23:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4539","BK4613","LU1861559042.SGD","BK4548","TEM","TEMC","ARKG","BK4121","BK4611","HEAL","BK4139","LU1861558580.USD","BK4609","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669161540","title":"Tempus AI, Recursion Extend Data License, Amend Fee Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669161540","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669161540?lang=en_us&edition=fundamental","pubTime":"2026-09-21 22:36","pubTimestamp":1790001417,"startTime":"0","endTime":"0","summary":"Tempus AI  and Recursion Pharmaceuticals  extended their data license agreement through November 2029 and revised the contract's fee structure.Up to $84 million in discretionary payments over the next two years will be replaced with $42 million in committed payments over three years, Tempus said Monday in a statement.Tempus said it also signed a separate agreement granting the company a nonexclusive, worldwide license to Recursion's proprietary RNA sequencing model.Tempus shares rose 1.8% in Monday trading, and Recursion climbed 2.6%.Price: 79.27, Change: +1.43, Percent Change: +1.83","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4613","LU1861559042.SGD","TEM","BK4539","BK4139","HEAL","TEMT","LU1861558580.USD","BK4611","BK4121","BK4609","TEMC","RXRX","ARKG","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169875","title":"Recursion, Tempus Expand AI and RNA Collaboration Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169875?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:29","pubTimestamp":1789997370,"startTime":"0","endTime":"0","summary":"The latest update is out from Recursion Pharmaceuticals ( ($RXRX) ). On September 15, 2026, Recursion Pharmaceuticals amended its long-term data an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXRX","BK4139","HEAL","TEM","TEMC","ARKG","BK4539","BK4548","LU1861559042.SGD","LU1861558580.USD","BK4121","BK4613","TEMT","BK4611","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169889","title":"Tempus AI, Recursion extend data license agreement, enter new license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169889?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:20","pubTimestamp":1789996814,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an extension of its data license agreement with Recursion Pharmaceuticals (RXRX). Additionally, the two companies have en...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXRX","BK4139","HEAL","TEM","TEMC","ARKG","BK4539","BK4548","LU1861559042.SGD","LU1861558580.USD","BK4121","BK4613","TEMT","BK4611","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669666681","title":"Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm","url":"https://stock-news.laohu8.com/highlight/detail?id=2669666681","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669666681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4611","BK4613","HEAL","TEM","TEMC","TEMT","LU1861559042.SGD","RXRX","BK4609","LU1861558580.USD","BK4548","BK4121","BK4539","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166574","title":"Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166574?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","HEAL","TEMT","ARKG","BK4609","BK4539","TEM","RXRX","BK4121","BK4548","BK4139","LU1861559042.SGD","TEMC","LU1861558580.USD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166572","title":"Tempus AI, -Co and Recursion Extend Data Partnership Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166572","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166572?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMT","TEM","HEAL","BK4613","TEMC","ARKG","LU1861559042.SGD","BK4121","BK4548","BK4539","BK4139","BK4609","RXRX","BK4611","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669816691","title":"Hexcel to showcase advanced composite innovations at CAMX 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669816691","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669816691?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:10","pubTimestamp":1789996244,"startTime":"0","endTime":"0","summary":"Hexcel (HXL) will showcase new materials, qualification milestones and manufacturing innovations at the Composites and Advanced Materials Expo 2026...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hexcel-to-showcase-advanced-composite-innovations-at-camx-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hexcel-to-showcase-advanced-composite-innovations-at-camx-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4544","CAMX","LU0240878834.USD","BK4585","BZZ","LU0205194284.USD","LU0205193047.USD","UYM","BK4588","HXL","BK4187","EES","ROKT","LU0240877869.USD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150390","title":"10x Genomics : Deutsche Bank Raises Target Price to $70 from $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150390?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:58","pubTimestamp":1789988317,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nAQN2MK4RR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARKG","LU1861559042.SGD","BK4121","LU0963586101.USD","BK4585","LU1861558580.USD","TXG","BK4548","BK4588","FMED"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}